Search research articles
Contact Us
Filters
Showing results (111-120 of 248) with videos related to
Page
of 25
Sort By:
Antimicrobial Agents and Chemotherapy
|
August 1, 2018
Population Pharmacokinetics of Artemether, Dihydroartemisinin, and Lumefantrine in Rwandese Pregnant Women Treated for Uncomplicated Plasmodium falciparum Malaria
Jesmin Lohy Das, Stephen Rulisa, Peter J de Vries, et al.
Plos One
|
August 19, 2014
Efficacy and day 7 plasma piperaquine concentrations in African children treated for uncomplicated malaria with dihydroartemisinin-piperaquine
Issaka Zongo, Fabrice A Somé, Serge A M Somda, et al.
Malaria Journal
|
October 4, 2024
Safety and pharmacokinetic properties of a new formulation of parenteral artesunate in healthy Thai volunteers
Joel Tarning, Borimas Hanboonkunupakarn, Richard M Hoglund, et al.
Science Translational Medicine
|
March 18, 2021
Structure-switching aptamer sensors for the specific detection of piperaquine and mefloquine
Erin S Coonahan, Kyung-Ae Yang, Stevan Pecic, et al.
The AAPS Journal
|
December 11, 2012
External validation of the bilirubin-atazanavir nomogram for assessment of atazanavir plasma exposure in HIV-1-infected patients
Dinko Rekić, Daniel Röshammar, Martin Bergstrand, et al.
Malaria Journal
|
February 27, 2016
Clinical trials of artesunate plus sulfadoxine-pyrimethamine for Plasmodium falciparum malaria in Afghanistan: maintained efficacy a decade after introduction
Ghulam Rahim Awab, Mallika Imwong, Sasithon Pukrittayakamee, et al.
Antimicrobial Agents and Chemotherapy
|
December 25, 2019
Differential Impact of Nevirapine on Artemether-Lumefantrine Pharmacokinetics in Individuals Stratified by <i>CYP2B6</i> c.516G>T Genotypes
Sa'ad T Abdullahi, Julius O Soyinka, Adeniyi Olagunju, et al.
Journal of Clinical Pharmacology
|
September 25, 2019
CYP2B6*6 Genotype Specific Differences in Artemether-Lumefantrine Disposition in Healthy Volunteers
Sa'ad T Abdullahi, Julius O Soyinka, Adeniyi Olagunju, et al.
The Journal of Antimicrobial Chemotherapy
|
June 4, 2014
Pharmacokinetics of co-formulated mefloquine and artesunate in pregnant and non-pregnant women with uncomplicated Plasmodium falciparum infection in Burkina Faso
Innocent Valea, Halidou Tinto, Maminata Traore-Coulibaly, et al.
Antimicrobial Agents and Chemotherapy
|
December 25, 2013
Pharmacokinetics of orally administered oseltamivir in healthy obese and nonobese Thai subjects
Podjanee Jittamala, Sasithon Pukrittayakamee, Joel Tarning, et al.
Page
of 25
Search research articles
Search
Showing results (111-120 of 248) with videos related to
Sort By:
Page
of 25
Antimicrobial Agents and Chemotherapy
|
August 1, 2018
Population Pharmacokinetics of Artemether, Dihydroartemisinin, and Lumefantrine in Rwandese Pregnant Women Treated for Uncomplicated Plasmodium falciparum Malaria
Jesmin Lohy Das, Stephen Rulisa, Peter J de Vries, et al.
Plos One
|
August 19, 2014
Efficacy and day 7 plasma piperaquine concentrations in African children treated for uncomplicated malaria with dihydroartemisinin-piperaquine
Issaka Zongo, Fabrice A Somé, Serge A M Somda, et al.
Malaria Journal
|
October 4, 2024
Safety and pharmacokinetic properties of a new formulation of parenteral artesunate in healthy Thai volunteers
Joel Tarning, Borimas Hanboonkunupakarn, Richard M Hoglund, et al.
Science Translational Medicine
|
March 18, 2021
Structure-switching aptamer sensors for the specific detection of piperaquine and mefloquine
Erin S Coonahan, Kyung-Ae Yang, Stevan Pecic, et al.
The AAPS Journal
|
December 11, 2012
External validation of the bilirubin-atazanavir nomogram for assessment of atazanavir plasma exposure in HIV-1-infected patients
Dinko Rekić, Daniel Röshammar, Martin Bergstrand, et al.
Malaria Journal
|
February 27, 2016
Clinical trials of artesunate plus sulfadoxine-pyrimethamine for Plasmodium falciparum malaria in Afghanistan: maintained efficacy a decade after introduction
Ghulam Rahim Awab, Mallika Imwong, Sasithon Pukrittayakamee, et al.
Antimicrobial Agents and Chemotherapy
|
December 25, 2019
Differential Impact of Nevirapine on Artemether-Lumefantrine Pharmacokinetics in Individuals Stratified by <i>CYP2B6</i> c.516G>T Genotypes
Sa'ad T Abdullahi, Julius O Soyinka, Adeniyi Olagunju, et al.
Journal of Clinical Pharmacology
|
September 25, 2019
CYP2B6*6 Genotype Specific Differences in Artemether-Lumefantrine Disposition in Healthy Volunteers
Sa'ad T Abdullahi, Julius O Soyinka, Adeniyi Olagunju, et al.
The Journal of Antimicrobial Chemotherapy
|
June 4, 2014
Pharmacokinetics of co-formulated mefloquine and artesunate in pregnant and non-pregnant women with uncomplicated Plasmodium falciparum infection in Burkina Faso
Innocent Valea, Halidou Tinto, Maminata Traore-Coulibaly, et al.
Antimicrobial Agents and Chemotherapy
|
December 25, 2013
Pharmacokinetics of orally administered oseltamivir in healthy obese and nonobese Thai subjects
Podjanee Jittamala, Sasithon Pukrittayakamee, Joel Tarning, et al.
Page
of 25